Details for New Drug Application (NDA): 201820
✉ Email this page to a colleague
The generic ingredient in BETHKIS is tobramycin. There are eighteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the tobramycin profile page.
Summary for 201820
Tradename: | BETHKIS |
Applicant: | Chiesi |
Ingredient: | tobramycin |
Patents: | 0 |
Suppliers and Packaging for NDA: 201820
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BETHKIS | tobramycin | SOLUTION;INHALATION | 201820 | NDA | Chiesi USA, Inc. | 10122-820 | 10122-820-04 | 4 AMPULE in 1 POUCH (10122-820-04) / 4 mL in 1 AMPULE |
BETHKIS | tobramycin | SOLUTION;INHALATION | 201820 | NDA | Chiesi USA, Inc. | 10122-820 | 10122-820-28 | 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | 300MG/4ML | ||||
Approval Date: | Oct 12, 2012 | TE: | AN | RLD: | Yes |
Expired US Patents for NDA 201820
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | BETHKIS | tobramycin | SOLUTION;INHALATION | 201820-001 | Oct 12, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | BETHKIS | tobramycin | SOLUTION;INHALATION | 201820-001 | Oct 12, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | BETHKIS | tobramycin | SOLUTION;INHALATION | 201820-001 | Oct 12, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription